ethyl 2-hydroxy-4-(1-methyl-1H-pyrazol-4-yl)-4-oxobut-2-enoate, 98%, 250mg

3-((Tert-butoxycarbonyl)amino)-3-(thiophen-3-yl)propanoic acid, 95%, 25g

(2Z)-2-(1H-1,2,3-Benzotriazol-1-yl)-3-(4-methylphenyl)-1-phenylprop-2-en-1-one, 90.0%, 10mg

2-Ethyl 6-methyl 1H-indole-2,6-dicarboxylate, 95.0%, 250mg

2-(1,3-Benzoxazol-2-yl)-1-[4-(trifluoromethyl)phenyl]ethanone, 97.0%, 25g

Acide formique, 45 %, pur, 25 l, emballage plastique.

MagSi-STA 3,0 L, 10 ml

Lithium difluoro(oxalato)borate, 95.0%, 5g

(4Z)-4-(ethoxymethylene)isoquinoline-1,3(2H,4H)-dione, 250mg

2-Butyn-1-amine, hydrochloride, 95%, 250mg

Undecan-1-ol, 98.0%, 100g

(S)-4-Hydroxypiperidin-2-one, 95.0%, 100mg

6-Methoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid, 95.0%, 1g